EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...
AI-enabled products and features are squeezing margins, usage-based monetization is now mainstream, and data gaps amplify customer retention challengesITASCA, Ill., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback